Menu Search
Equities

Gentian Diagnostics ASA

6FK:STU

Gentian Diagnostics ASA

Actions
  • Price (EUR)3.40
  • Today's Change-0.06 / -1.73%
  • Shares traded0.00
  • 1 Year change+15.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in NOKIncome statement in NOKView more

Year on year Gentian Diagnostics ASA grew revenues 32.98% from 101.64m to 135.15m while net income improved from a loss of 23.62m to a smaller loss of 10.65m.
Gross margin51.69%
Net profit margin1.51%
Operating margin-0.03%
Return on assets1.18%
Return on equity1.40%
Return on investment1.33%
More ▼

Cash flow in NOKView more

In 2023, Gentian Diagnostics ASA increased its cash reserves by 7.41%, or 6.04m. The company earned 15.46m from its operations for a Cash Flow Margin of 11.44%. In addition the company used 4.88m on investing activities and also paid 4.60m in financing cash flows.
Cash flow per share0.7222
Price/Cash flow per share55.74
Book value per share10.47
Tangible book value per share8.78
More ▼

Balance sheet in NOKView more

Gentian Diagnostics ASA has little financial risk as the capital structure does not rely on leverage.
Current ratio7.04
Quick ratio5.01
Total debt/total equity0.041
Total debt/total capital0.0394
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.